C-CAR031 is based on a novel GPC3-targeting CAR-T (AZD5851) designed by AstraZeneca using their transforming growth factor-beta receptor II
Approval based on results from TOPAZ-1 global Phase III trial and a Chinese patient
Evonik China and Shandong Vland Biotech agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes
The €70 million investment will allow the large-scale manufacturing of high-purity reagents for quality control and testing for biopharma customers, increasing annual output by several thousand tons
The new range of HDPE bottles is compliant with US FDA, EU regulations and Chinese DMF registration for use in dry pharmaceutical applications
The randomised, multi-centre, evaluator blinded, parallel group, active controlled Phase 3 trial is being led by Lanhzou Biotechnique Development
elanese now offers Zytel Resin, Hytrel TPC, Crastin PBT and Micromax Electronic Inks and Paste following its 2022 acquisition of the majority of the Mobility & Materials (M&M) business from DuPont
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Subscribe To Our Newsletter & Stay Updated
